Intervention

Inhaled treprostinil

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting0

Common conditions2

Lead sponsors shown2

Clinical trials

4 shown

Effects of Inhaled Treprostinil on Exercise Performance in Exercise Induced Pulmonary HypertensionNCT07116681 · 2025-10-01

NOT_YET_RECRUITING

Safety and Efficacy of Inhaled Treprostinil in Patients With PAHNCT01557647 · 2012-06-01

Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) SubjectsNCT00741819 · 2008-09-01

Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)NCT00147199 · 2005-06-01

Common conditions

Pulmonary Arterial Hypertension2 Pulmonary Hypertension2

Leading sponsors

United Therapeutics3 University of California, San Diego1

Trial status mix

COMPLETED2

NOT_YET_RECRUITING1

WITHDRAWN1

Phase mix

PHASE32

EARLY_PHASE11

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.